CARDENE IV
nicardipine hydrochloride
- Strength
- .2 mg/mL
- Form
- Injection, Solution
- Class
- Dihydropyridine Calcium Channel Blocker
Baxter Healthcare Corporation
Not stocked by us — reference only
Listed by Cipla USA Inc.
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Dihydropyridine Calcium Channel Blocker |
| Approval route | ANDA — approved generic |
| NDC code | 69097-008 |
| FDA application | ANDA215592 |
| RxNorm concept | 858599 |
| Package sizes listed | 1 |
| Marketed since | October 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
nicardipine hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
Amerisyn LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.